Valeant Pharma adds hedge fund executive, 2 others to board

Embattled drug company Valeant Pharmaceuticals has added three directors to its board, including an executive from activist investor Bill Ackman's hedge fund Pershing Square Capital Management.

See Full Article

Its shares climbed nearly 4 per cent in premarket trading shortly ahead of the Wednesday market open.

The Canadian drugmaker said Wednesday that Pershing Vice Chairman Stephen Fraidin has joined the board, along with pharmaceutical executive Dr. Fred Eshelman and former University of North Carolina president Thomas W. Ross. Dr. Anders Lonner also is leaving, so these moves will bump the board's size to 14 members, 12 of whom are independent.

Pershing Square holds a 6.3 per cent stake in Valeant, as one of its biggest shareholders, according to FactSet.

Fraidin is an attorney specializing in mergers and acquisitions. Eshelman is the founder and former CEO of Pharmaceutical Product Development Inc. and has worked in the pharmaceutical industry for 35 years, Valeant said.

Valeant Pharmaceuticals International Inc. is facing a Securities and Exchange Commission investigation and, separately, scrutiny from Congress over its drug pricing. CEO Michael Pearson also recently returned to work after missing two months due to some health problems.

Valeant will discuss its preliminary fourth-quarter results and update its forecast for 2016 on March 15. The company had said last month it was delaying that announcement due to Pearson's return to work.

The company also has said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor, which has raised questions about the accuracy of Valeant's financial reporting.

U.S.-traded shares of Valeant jumped nearly 4 per cent, or $2.49, to $65.64 shortly before markets opening Wednesday. That's about a quarter of the all-time high of $263.81 that the stock reached in August, shortly before the company's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny.



Advertisements

Latest Economic News

  • Environmental groups challenge Keystone XL pipeline approval

    Economic CBC News
    A coalition of environmental groups challenged the U.S. federal permit for the Keystone XL oil pipeline in court on Thursday because they say additional environmental scrutiny is needed. The Sierra Club, Natural Resources Defense Council and other groups say the initial environmental review completed in 2014 is inadequate and outdated, and that it underestimated how much the pipeline would encourage tar sands oil production in Canada. Source
  • Cenovus shares fall in wake of $17.7B oilsands purchase

    Economic CBC News
    Shares in Cenovus Energy were down 11 per cent shortly after markets opened Thursday following its announcement to acquire Canadian assets belonging to Houston-based ConocoPhillips.Cenovus Energy buying most of ConocoPhillips' Canadian assets for $17.7BUnder the $17.7 billion deal, the Calgary-based energy company would take over most of ConocoPhillips's investments in Canada in what is the latest mega oilsands sale by a major foreign oil and gas producer. Source
  • Is Toronto's housing market in a bubble? Not quite, analyst says

    Economic CTV News
    Despite a recent declaration by Bank of Montreal Chief Economist Douglas Porter that Toronto’s red-hot housing market is indeed in a “bubble,” other economists have been hesitant to use the controversial label to describe the city’s current real estate boom. Source
  • CIBC boosts takeover offer for PrivateBancorp to more than $6B

    Economic CBC News
    Shares of Canadian Imperial Bank of Commerce traded lower Thursday after the bank boosted its takeover bid for PrivateBancorp by 20 per cent. Under the terms of a new takeover agreement that has approved by the boards of directors of both firms, the deal values Chicago-based PrivateBancorp at approximately $6.6 billion Cdn, or $60.92 US per share, Source
  • Air Canada lawsuit accuses Airbus of negligence in Halifax crash landing

    Economic CTV News
    HALIFAX - Air Canada is claiming a French aircraft manufacturer's negligence contributed to a crash landing at Halifax Stanfield International Airport two years ago. The Canadian airline is suing Airbus SAS, saying the company failed to identify shortcomings of the Airbus 320. Source
  • Trump takes first step in NAFTA renegotiation

    Economic CTV News
    WASHINGTON -- The Trump administration has taken an early step in renegotiating the North American Free Trade Agreement, sending the U.S. Congress a draft list of priorities for the negotiation that expresses hope for change in a broad range of areas. Source
  • Vague NAFTA renegotiation plan after Trump's tough talk

    Economic CTV News
    WASHINGTON -- The Trump administration has submitted a vague set of guidelines to Congress for renegotiating the North American Free Agreement with Mexico and Canada, disappointing those who wanted a major overhaul of a decades-old trade deal that Trump described as "disaster" during the presidential campaign. Source
  • Cenovus Energy stock slides after $17.7B deal with ConocoPhillips

    Economic CTV News
    CALGARY -- Shares in Cenovus Energy were down 11 per cent shortly after markets opened Thursday following its announcement to acquire Canadian assets belonging to Houston-based ConocoPhillips. Under the C$17.7 billion deal, the Calgary-based energy company would take over most of ConocoPhillips's investments in Canada in what is the latest mega oilsands sale by a major foreign oil and gas producer. Source
  • TD Bank reviewing sales practices, CEO Bharat Masrani tells AGM

    Economic CBC News
    TD Bank says it is reviewing concerns about its sales practices in light of reports that some employees allegedly broke the law in order to meet sales targets and keep their jobs. CEO Bharat Masrani says the bank received "a few hundred complaints" last year regarding its sales practices that were escalated. Source
  • TD Bank reviewing sales practice concerns: CEO

    Economic CTV News
    TORONTO -- TD Bank says it is reviewing concerns about its sales practices in light of reports that some employees allegedly broke the law in order to meet sales targets and keep their jobs. "As we have done in the past with matters of such importance, we will be relying on our board as well as the objective advice from a leading professional services firm to make sure we really test ourselves," CEO Bharat Masrani said during the bank's annual shareholder meeting Thursday. Source